Coenzyme Q10 tested as a possible remedy for train derailment symptoms
NCT ID NCT06962657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the supplement coenzyme Q10 can ease symptoms like fatigue and pain in people affected by the 2023 East Palestine, Ohio train derailment. Twenty participants will take either CoQ10 or a placebo for three months, then switch. The goal is not to prove benefit but to gather data for a future larger trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Coenzyme Q10 (ubiquinone) 100 mg oral soft gel
What this could lead to
If it works, this could point toward a way to reduce symptoms and improve quality of life for people exposed to toxic chemicals.
What could go wrong
This is a very small pilot study (20 people) not designed to prove benefit—only to see if a larger trial is worth doing. Results may not apply to others.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXICANT INDUCED CHRONIC MULTISYMPTOM ILLNESS AND ASSOCIATED SYMPTOMS AND COMORBIDITIES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC San Diego
La Jolla, California, 92093, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••